A list of this year’s newsworthy successes—and failures—in drug development
The Scientist
Most Recent
After the FDA revoked its approval of Avastin for the treatment of metastatic breast cancer, the drug maker says it will initiate new trials.
Despite drug company’s and patients’ pleading, an FDA panel votes to rescind Avastin approval for breast cancer.
Page 1 of 1
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
